APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 27 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 40,528,000 | $66,004,630 | 2.39% |
| LINDEN ADVISORS LP | 15,000,000 | $24,573,208 | 0.23% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $19,220,793 | 0.16% |
| Verition Fund Management LLC | 12,769 | $20,861,992 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,670,117 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 15,937,000 | $26,037 | 0.03% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $488,640 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $8,165,144 | 0.01% |
| CITIGROUP INC | 504,000 | $820,915 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |